Molecular pathology analyses of two fatal human infections of avian influenza A(H7N9) virus

Journal of Clinical Pathology

Volumn 68, Issue 1, 2015, Pages 57-63

  Feng, Yanling ^a   Hu, Lvyin ^a   Lu, Shuihua ^a   Chen, Qingguo ^a   Zheng, Ye ^a   Zeng, Dong ^a   Zhang, Jun ^a   Zhang, Anli ^a   Chen, Liang ^a   Hu, Yunwen ^a   Zhang, Zhiyong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; COMPLEMENT COMPONENT C4D; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; MESSENGER RNA; OSELTAMIVIR; PERAMIVIR; PIPERACILLIN PLUS TAZOBACTAM; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; VIRUS RNA; LEUKOCYTE ANTIGEN; LUNG SURFACTANT;

ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; AUTOPSY; CASE REPORT; CD3+ T LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CHEST TIGHTNESS; CLINICAL FEATURE; COMPLEMENT DEPOSITION; CONSCIOUSNESS LEVEL; CONTROLLED STUDY; COUGHING; CYTOKINE PRODUCTION; CYTOKINE STORM; CYTOTOXIC T LYMPHOCYTE; DRUG TREATMENT FAILURE; EPITHELIUM HYPERPLASIA; EXTRACORPOREAL OXYGENATION; FATALITY; FLU LIKE SYNDROME; HEART FAILURE; HELPER CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLUENZA A; INFLUENZA A (H7N9); INFLUENZA VIRUS A H7N9; LUNG ALVEOLUS CELL; LUNG PARENCHYMA; MACROPHAGE; MALE; MEMBRANE DAMAGE; MOLECULAR PATHOLOGY; MULTIPLE ORGAN FAILURE; NEUTROPHIL; NONHUMAN; TACHYPNEA; THROAT CULTURE; VERY ELDERLY; VIRUS PNEUMONIA; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; IMMUNOLOGY; INFLUENZA; MOUSE; PATHOLOGY;

AGED, 80 AND OVER; ANIMALS; ANTIGENS, CD; FATAL OUTCOME; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; MALE; MICE; MICE, INBRED C57BL; PATHOLOGY, MOLECULAR; PULMONARY SURFACTANTS;

EID: 84919399270     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2014-202441     Document Type: Article

References (21)

1. Gao R, Cao B, Hu Y, et al. Human infection with a novel avian-origin influenza A(H7N9) virus. N Engl J Med 2013;368:1888-97
2. Gao HN, Lu HZ, Cao B, et al. Clinical findings in 111 cases of influenza A(H7N9) virus infection. N Engl J Med 2013;368:2277-85
3. Hu Y, Lu S, Song Z, et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet 2013;381:2273-9
4. Wang Q, Zhang Z, Shi Y, et al. Emerging H7N9 influenza A (novel reassortant avian-origin) pneumonia: Radiologic findings. Radiology 2013;268:882-9
5. Bai T, Zhou J, Shu Y. Serologic study for influenza A(H7N9) among high-risk groups in China. N Engl J Med 2013;368:2339-40
6. Li Q, Zhou L, Zhou M, et al. Preliminary report: Epidemiology of the avian influenza A(H7N9) outbreak in China. N Engl J Med 2013;24:24
7. Yu L, Wang Z, Chen Y, et al. Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus. Clin Infect Dis 2013;57:1449-57
8. Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol 2008;3:499-522
9. Uiprasertkul M, Puthavathana P, Sangsiriwut K, et al. Influenza A H5N1 replication sites in humans. Emerg Infect Dis 2005;11:1036-41
10. Zhou J, Wang D, Gao R, et al. Biological features of novel avian influenza A(H7N9) virus. Nature 2013;499:500-3
11. Gu J, Xie Z, Gao Z, et al. H5N1 infection of the respiratory tract and beyond: A molecular pathology study. Lancet 2007;370:1137-45
12. Monsalvo AC, Batalle JP, Lopez MF, et al. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat Med 2011;17:195-9
13. Stegall MD, Chedid MF, Cornell LD. The role of complement in antibody-mediated rejection in kidney transplantation. Nat Rev Nephrol 2012;8:670-8
14. Kozel TR. Activation of the complement system by pathogenic fungi. Clin Microbiol Rev 1996;9:34-46
15. de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A(H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006;12:1203-7
16. Wang Z, Zhang A, Wan Y, et al. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc Natl Acad Sci USA 2014;111:769-74
17. Chi Y, Zhu Y, Wen T, et al. Cytokine and Chemokine levels in patients infected with the novel avian influenza A(H7N9) virus in China. J Infect Dis 2013;208:1962-7
18. Mok CK, Lee HH, Chan MC, et al. Pathogenicity of the novel A/H7N9 influenza virus in mice. MBio 2013;4
19. Khubchandani KR, Snyder JM. Surfactant protein A (SP-A): The alveolus and beyond. FASEB J 2001;15:59-69
20. Benne CA, Kraaijeveld CA, van Strijp JA, et al. Interactions of surfactant protein A with influenza A viruses: Binding and neutralization. J Infect Dis 1995;171:335-41
21. Yang S, Chen Y, Cui D, et al. Avian-origin influenza A(H7N9) infection in influenza A(H7N9)-affected areas of China: A serological study. J Infect Dis 2013;209:265-9